# Deferasorox

NDC: 72205-075
Generic name: Deferasirox
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20210318

FDA application: ANDA214650

## Active ingredients

- DEFERASIROX: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-075"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-075
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1122f1c0-c160-49db-a31b-90d7521370f5